These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction. Klingele M, Stadler T, Fliser D, Speer T, Groesdonk HV, Raddatz A. Crit Care; 2017 Nov 29; 21(1):294. PubMed ID: 29187232 [Abstract] [Full Text] [Related]
3. Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis. Zhang W, Bai M, Yu Y, Li L, Zhao L, Sun S, Chen X. Crit Care; 2019 Jan 24; 23(1):22. PubMed ID: 30678706 [Abstract] [Full Text] [Related]
4. Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children. Raymakers-Janssen PAMA, Lilien M, van Kessel IA, Veldhoen ES, Wösten-van Asperen RM, van Gestel JPJ. Pediatr Nephrol; 2017 Oct 24; 32(10):1971-1978. PubMed ID: 28578542 [Abstract] [Full Text] [Related]
5. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults. Gattas DJ, Rajbhandari D, Bradford C, Buhr H, Lo S, Bellomo R. Crit Care Med; 2015 Aug 24; 43(8):1622-9. PubMed ID: 25853591 [Abstract] [Full Text] [Related]
6. Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study. Schultheiß C, Saugel B, Phillip V, Thies P, Noe S, Mayr U, Haller B, Einwächter H, Schmid RM, Huber W. Crit Care; 2012 Aug 22; 16(4):R162. PubMed ID: 22913794 [Abstract] [Full Text] [Related]
7. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation. Khadzhynov D, Schelter C, Lieker I, Mika A, Staeck O, Neumayer HH, Peters H, Slowinski T. J Crit Care; 2014 Apr 22; 29(2):265-71. PubMed ID: 24360392 [Abstract] [Full Text] [Related]
8. Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials. Zhou Z, Liu C, Yang Y, Wang F, Zhang L, Fu P. Crit Care; 2023 Jun 07; 27(1):222. PubMed ID: 37287084 [Abstract] [Full Text] [Related]
9. Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure. Rodriguez K, Srivaths PR, Tal L, Watson MN, Riley AA, Himes RW, Desai MS, Braun MC, Akcan Arikan A. PLoS One; 2017 Jun 07; 12(8):e0182134. PubMed ID: 28792509 [Abstract] [Full Text] [Related]
10. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials. Liu C, Mao Z, Kang H, Hu J, Zhou F. Crit Care; 2016 May 13; 20(1):144. PubMed ID: 27176622 [Abstract] [Full Text] [Related]
11. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial. Zarbock A, Küllmar M, Kindgen-Milles D, Wempe C, Gerss J, Brandenburger T, Dimski T, Tyczynski B, Jahn M, Mülling N, Mehrländer M, Rosenberger P, Marx G, Simon TP, Jaschinski U, Deetjen P, Putensen C, Schewe JC, Kluge S, Jarczak D, Slowinski T, Bodenstein M, Meybohm P, Wirtz S, Moerer O, Kortgen A, Simon P, Bagshaw SM, Kellum JA, Meersch M, RICH Investigators and the Sepnet Trial Group. JAMA; 2020 Oct 27; 324(16):1629-1639. PubMed ID: 33095849 [Abstract] [Full Text] [Related]
12. Regional citrate anticoagulation for continuous renal replacement therapy in newborns and infants: Focus on citrate accumulation. Persic V, Vajdic Trampuz B, Medved B, Pavcnik M, Ponikvar R, Gubensek J. Artif Organs; 2020 May 27; 44(5):497-503. PubMed ID: 31851381 [Abstract] [Full Text] [Related]
13. Regional citrate anticoagulation in critically ill patients with liver and kidney failure. Balogun RA, Turgut F, Caldwell S, Abdel-Rahman EM. J Nephrol; 2012 May 27; 25(1):113-9. PubMed ID: 21607918 [Abstract] [Full Text] [Related]
14. The effect of regional citrate anti-coagulation on the coagulation system in critically ill patients receiving continuous renal replacement therapy for acute kidney injury - an observational cohort study. Fisher R, Lei K, Mitchell MJ, Moore GW, Dickie H, Tovey L, Crichton S, Ostermann M. BMC Nephrol; 2017 Oct 02; 18(1):304. PubMed ID: 28969597 [Abstract] [Full Text] [Related]
15. Citrate anticoagulation for continuous renal replacement therapy in the critically ill. Oudemans-van Straaten HM. Blood Purif; 2010 Oct 02; 29(2):191-6. PubMed ID: 20093826 [Abstract] [Full Text] [Related]
16. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial. Schilder L, Nurmohamed SA, Bosch FH, Purmer IM, den Boer SS, Kleppe CG, Vervloet MG, Beishuizen A, Girbes AR, Ter Wee PM, Groeneveld AB, CASH study group. Crit Care; 2014 Aug 16; 18(4):472. PubMed ID: 25128022 [Abstract] [Full Text] [Related]